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Abstract 
Background 
Length of hospital stay (LOS) is a surrogate marker for patients’ well-being during hospital 
treatment and is associated with health care costs.  Identifying pretreatment factors associated 
with LOS in surgical patients may enable early intervention in order to reduce postoperative 
LOS.   
Methods 
This cohort study enrolled 157 patients with suspected or proven gynecological cancer at a 
tertiary cancer centre (2004-2006).  Before commencing treatment, the scored Patient 
Generated - Subjective Global Assessment (PG-SGA) measuring nutritional status and the 
Functional Assessment of Cancer Therapy-General (FACT-G) scale measuring quality of life 
(QOL) were completed.  Clinical and demographic patient characteristics were prospectively 
obtained. Patients were grouped into those with prolonged LOS if their hospital stay was 
greater than the median LOS and those with average or below average LOS.  
Results 
In univariate models prolonged LOS was associated with low serum albumin or hemoglobin, 
malnutrition (PG-SGA score and PG-SGA group B or C), low pretreatment FACT-G score, 
the occurrence of surgical adverse events and diagnosis of cancer.  In multivariable models 
adjusted for pretreatment clinical diagnosis, PG-SGA group B or C, FACT-G score 
independently predicted LOS. 
Conclusions 
Malnutrition, low quality of life scores and being diagnosed with advanced ovarian cancer are 
the major determinants of LOS amongst gynecological cancer patients. Interventions 
addressing malnutrition and poor QOL may decrease LOS in gynecological cancer patients.  
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Background 
Despite significant advances in cancer therapy, in-patient hospital care remains a major 
expense in the treatment of patients with gynecological cancer. Reducing length of hospital 
stay (LOS) has the potential to reduce health care cost, risk of infections and other hospital 
acquired diseases, and to improve patients’ quality of life (QOL). Previous studies have 
observed differential LOS by cancer type and stage, however, these characteristics commonly 
are not available before surgery, and thus are not amenable to pre-treatment interventions. 
Identifying modifiable risk factors at admission predicting (LOS) could lead to appropriately 
targeted interventions to improve the delivery of care for women with gynecological cancer. 
Previous research has shown that preoperative serum albumin (a marker of chronic 
malnutrition), hemoglobin and lymphocyte status are associated with LOS and mortality in 
the gynecological oncology setting [1-4].  Preoperative medical conditions or co-morbidities 
could also be associated with LOS; however findings regarding these predictors are 
inconsistent [4, 5]. 
Acute malnutrition may be a further potentially amenable risk factor for LOS. Malnutrition 
has been found to be associated with increased risk of morbidity and mortality, complication 
rates such as wound infections, costs of hospitalisation, and decreased QOL in various cancer 
populations [2, 4, 6-16]. The scored Patient Generated - Subjective Global Assessment (PG-
SGA) is a validated nutritional assessment tool specifically designed for cancer patients. 
Using the PG-SGA, we have observed high levels of nutritional deficiencies among patients 
with gynecological cancer, especially those diagnosed with ovarian cancer [17, 18], but to 
date no study has assessed whether the scored PG-SGA can predict prolonged LOS among 
gynecological cancer patients. 
Gynecological cancer and/or malnutrition can have a profound impact on patients’ physical 
function and psychosocial well-being – both important components of QOL. One common 
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definition of QOL is that it is a subjective, multidimensional construct representing functional 
status, mental and social well-being as well as general health [19]. Health-related QOL before 
treatment commences has been suggested as an important prognostic factor in ovarian cancer 
patients [20, 21]. To our knowledge, no study to date evaluated the association between 
preoperative QOL, malnutrition and LOS among a wider range of gynecological cancer 
patients.  
Thus, the purpose of this study was to evaluate factors available prior to initial treatment to 
predict LOS in patients with suspected or proven gynecological cancer and to assess their 
independent contribution once post-treatment (histology, stage and adverse events) 
information was considered.  
Methods 
The study was conducted at the Queensland Centre for Gynecological Cancer at the Royal 
Brisbane and Women’s Hospital, Brisbane, Australia. Patients with presumed or proven 
primary gynecological cancer were screened for eligibility at their preoperative visit between 
March 2004 and December 2006. Patients were excluded from the study if they presented 
with recurrent cancer, had received treatment for other cancers within the past five years, had 
psychological or cognitive impairments (e.g. schizophrenia, dementia) or were non-English 
speaking. A total of 194 patients gave informed written consent. Thirty-two study participants 
declined to complete the Functional Assessment of Cancer Therapy-General (FACT-G) 
questionnaire and five participants had to be excluded from analyses due to incomplete data. 
Overall, 157 women completed both the scored PG-SGA and the FACT-G questionnaire 
before commencing treatment. Patients’ clinical and demographic characteristics including 
age at study entry, body mass index, serum albumin, hemoglobin, lymphocytes, co-
morbidities, adverse events, surgical approach, LOS, and histopathological diagnosis and 
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staging according to the International Federation of Gynecology and Obstetrics (FIGO) were 
recorded prospectively. Six women did not undergo surgery, because a surgical approach was 
contraindicated or chemotherapy and/or radiotherapy was initiated as the primary treatment. 
Pre-treatment serum albumin levels were recorded in 146 patients; hemoglobin and 
lymphocyte count in 153 patients and actual body weight and height for all but one patient. 
All pre-treatment predictive factors were collected either at the outpatient or preadmission 
clinic, typically one to five weeks before primary treatment was initiated. The median waiting 
time for surgery was two weeks for ovarian and cervical cancers and five weeks for 
endometrial cancer and women with suspected benign diseases, respectively.  Women were 
categorised according to their clinical diagnosis before surgery: pelvic mass, or suspected 
advanced ovarian cancer, cervical cancer or endometrial cancer. This study has been 
approved by The Royal Brisbane and Women’s Hospital Human Research Ethics Committee 
(Protocol Number 2004/007) and the University of Queensland Medical Research Ethics 
Committee (Brisbane, Australia; Project Number 2006000533). 
 
Nutritional assessment 
The scored PG-SGA is a validated nutritional assessment tool for cancer patients [9, 16] that 
records and summarizes weight changes, alterations in food intake, gastrointestinal symptoms 
(such as nausea, vomiting and diarrhoea that have persisted for two weeks), and changes in 
functional capacity and physical signs of malnutrition. These signs were assessed by a trained 
clinical dietician using skinfold measurements (loss of subcutaneous fat, muscle wasting, 
edema). The presence of ascites was established radiologically and abstracted from the 
clinical notes for this study. Based on the global rating, women were classified as well 
nourished (PG-SGA A); moderately malnourished or suspected of being malnourished (PG-
SGA B); or severely malnourished (PG-SGA C). The PG-SGA also incorporates a numerical 
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score (PG-SGA score). Typical scores achieved by gynaecological cancer patients range from 
0-28 [22], with higher scores reflecting greater risk of malnutrition. Scores of nine or more 
indicate a critical need for nutritional intervention options and/or improved symptom 
management [23] . 
 
QOL assessment 
QOL was measured by the FACT-G questionnaire, which is a widely utilized and validated 
instrument [24]. Version 4 of the FACT-G is a 27-item self-report measure and allows 
patients to rate their current physical (7 items, range: 0-28), social and family (7 items, range: 
0-28), emotional (6 items, range: 0-24), and functional well-being (7 items, range: 0-28). The 
FACT-G is scored using a 5-point scale (0 = not at all, 1 = a little bit, 2 = somewhat, 3 = 
quite a bit, 4 = very much). The raw scores were are linearly transformed as per questionnaire 
manual with higher scores indicating better QOL [25]. 
 
Statistical analysis 
Descriptive statistics were used to summarize patient characteristics and to group patients by 
the main outcome variable (average versus prolonged LOS). Prolonged LOS was defined as 
LOS of greater than five days for patients who underwent open abdominal surgery and 
greater than two days for patients who underwent vaginal of laparoscopic surgery. Univariate 
logistic regression analyses were conducted to calculate odds ratios adjusted for age and 
surgical approach for patients who had prolonged compared to average LOS.   
Variables significantly associated with LOS were then entered into a multivariable model  
(Table 1).  
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All models described above were adjusted for age and surgical approach (open-abdominal, 
vaginal or laparoscopic surgery). Hosmer-Lemeshow goodness-of-fit statistic assessed fit of 
the models. SPSS software version 16.0 Graduate Student (SPSS Inc., Chicago, IL, USA) 
was used for the statistical analyses. 
 
Results 
Patient Characteristics 
Patients’ mean age was 58 years (SD 14 years). Preoperatively, 81 (52%) patients presented 
with a pelvic mass, 23 (15%) were suspected to have advanced ovarian cancer, 36 (23%) 
patients to have endometrial cancer, and 17 (11%) patients to have cervical cancer. Ninety-
four patients were operated using an open-abdominal, 40 patients with a laparoscopic and 17 
patients with a vaginal surgical approach. Data on patients’ weight, body mass index, 
albumin and PG-SGA have been reported in previous publications [17, 22]. 
LOS and potential predictors 
The median LOS for all patients in the study was 5 days (range 0-43 days). In total, 75 
(48.1%) of the patients had prolonged LOS (Table 1).  Patients with prolonged LOS were 
significantly older (mean age 62.8 years, SD 13.7) than patients with average LOS (mean age 
54.5 years, SD 13.6) (p<0.01).  
BMI was not significantly associated with LOS. Although fifty patients had two or more pre-
existing medical co-morbidities, neither the number (Table 1), nor the specific type of co-
morbidity (data not shown), were significantly different between patients with average and 
prolonged LOS.  Low pretreatment serum albumin or hemoglobin levels, low QOL FACT-G 
scores and high PG-SGA scores were associated with prolonged LOS. Compared to patients 
with a suspicious pelvic mass, patients suspected to carry an advanced ovarian cancer were 
significantly more likely to have prolonged LOS (OR = 30.4; 95% CI = 3.9-236.7) (Table 1).  
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In the multivariable model, patients with good quality  
 
 
of life a diagnosis of ovarian cancer stage I or II (OR=8.13, 95% CI 1.8-36.4) or ovarian 
cancer stage III or IV (OR = 29.8, 95% CI 3.4-261.4) remained the only significant post-
surgical factor significantly associated with prolonged LOS (Table 2). 
Combining the significant predictors from the previous two models the FACT-G global score 
and a diagnosis of ovarian cancer remained independently statistically significant, while 
nutritional status and the occurrence of AEs failed to reach a significant association with 
prolonged LOS in this combined model (Table 3).  
 
Discussion 
This study assesses factors predictive for prolonged LOS (defined as >5 days or >2 days, for 
patients who had open abdominal or laparoscopic surgery, respectively) among gynecological 
cancer patients.  Malnutrition and low QOL are predictors of prolonged LOS independent of 
patients’ age at diagnosis, surgical approach (laparoscopy or laparotomy), albumin and 
hemoglobin when only factors known prior to commencement of treatment are considered.   
Previous studies have shown that malnutrition was associated with prolonged LOS in 
hospitalized patients requiring treatment for various types of cancer [13, 16, 26-28]. The 
present manuscript is the first to confirm those findings for patients with gynecological 
cancer, and extends these findings even further. The present data suggest an association 
between pre-operative malnutrition and LOS based on both the PG-SGA global rating and the 
PG-SGA score. To our knowledge there is only one previous study which assessed the PG-
SGA score (as opposed to the global rating) and LOS [15]. Thomas and colleagues found a 
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weak correlation between LOS and the PG-SGA score [15], and similar in our study the PG-
SGA score was the weaker predictor compared to the global rating in multivariable analysis. 
However, the PG-SGA score provides dieticians with suggested appropriate intervention 
strategies and thus can be a clinically useful adjunct to the global rating. 
Our findings show that LOS was not equally distributed between tumor types. Even after 
adjustment for age and surgical approach, 88% of all ovarian cancer patients had prolonged 
hospital stay, compared with only 59% of patients with endometrial cancer and 26% of 
patients with benign disease.  In our previous work we described in detail that malnutrition 
was almost exclusively present in ovarian cancer patients compared to other gynecologic 
oncology diagnoses [17], which is the most likely reason why irrespective of nutritional 
status, ovarian cancer was so strongly associated with long LOS.  
A previous study by Dean and colleagues found that gynecological cancer patients with two 
or more pre-existing co-morbidities had significantly longer LOS than those with one or no 
co-morbidities [5]. In contrast, our findings suggest that in this sample of gynecological 
cancer patients, neither the number of co-morbidities nor the type of co-morbidity are 
predictive of prolonged LOS. Further studies are required to validate these findings, carefully 
separating preoperative co-morbidities from postoperative complications. 
In this study, we found low preoperative hemoglobin and lymphocyte counts in a small 
number of patients and these patients were more likely to experience prolonged LOS, but this 
difference was not statistically significant in adjusted modelling.  Previous studies suggested 
that low hemoglobin levels were related to poor survival in patients with ovarian cancer [29, 
30], and studies differed in their conclusions regarding the importance of age, histology, 
nutritional status and immune system on lymphocyte counts [31-33]. With our non-
significant results, we suggest that neither of these markers are suitable factors to predict 
prolonged LOS. 
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A third biochemical marker assessed in the present study was serum albumin, generally 
believed to indicate the presence of chronic malnutrition.  Previous studies have 
demonstrated an association between low serum albumin and increased postoperative 
complications [6, 34, 35], as well as reductions in survival in ovarian cancer patients [36]. 
The results of our study confirmed previous findings by Massad and colleagues in which they 
found an inverse correlation between serum albumin and LOS among patients with 
gynecological cancer [4]. However, our current results demonstrated when albumin and PG-
SGA global rating [22] were assessed concurrently, the PG-SGA was a stronger predictor of 
LOS, and therefore more sensitive to detect malnutrition in gynecological cancer patients. 
Research conducted on QOL and nutritional status in cancer patients indicates that nutritional 
support may lead to better QOL [11, 37, 38].  To our knowledge few investigations have 
examined the association between patients’ pre-treatment QOL and prolonged LOS, while 
concurrently assessing malnutrition. One study by Rogers and colleagues found a weak 
correlation between better QOL and shorter LOS in oral and oropharyngeal cancer patients 
[39]. In the present study we found that poor QOL prior to initial treatment was associated 
with prolonged LOS, and this association remained significant when adjusted for tumour 
stage/histology. Our results suggest that subsequent studies should assess the effect of pre-
surgical nutritional interventions, or interventions aimed at improving QOL on LOS. 
A limitation of our study was that data on nutritional status and QOL were only assessed 
before commencement of initial treatment and not at any time point afterwards.  This 
additional information would have been of interest to identify whether changes in patients’ 
PG-SGA score and global rating and FACT-G score are more influential for LOS than pre-
treatment score alone. In addition, given the preponderance of malnutrition among ovarian 
cancer patients, subsequent studies should focus on this subgroup of gynecological cancer 
patients.  However, our study also has some major strengths, including the availability of pre-
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treatment assessments for all patients, and the high participation rate among patients with 
gynecological cancer.  
 
Conclusions 
In conclusion, prolonged LOS was found to be associated with low QOL and a diagnosis of 
ovarian cancer, irrespective of malnutrition.  Strategies to reduce LOS and improve patients’ 
well-being during hospital stay will need to address potentially modifiable factors, which 
include QOL and malnutrition.  
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Table 1:  Pre-surgery factors associated with prolonged LOS  
     % (n) with  Univariate model 1  Multivariable model 2 
  N   prolonged LOS  OR 95% CI P  OR 95% CI P 
Total  157   48.1 (75)         
Body mass index              
  Underweight (<18.5)  3   66.7 (2)  2.96 0.12 -70.3 0.50    
  Normal (18.5-24.99)  39   46.2 (18)  Reference group     
  Overweight (25.0-29.99)  47   44.7 (21)  0.91 0.36 -2.30 0.84    
  Obese (≥30)  67   50.7 (34)  1.31 0.55 - 3.16 0.54    
Pre-existing co-morbidity              
    No or 1 co-morbidity  107   45.8 (49)  Reference group      
    2 or more co-morbidities  50   54.0 (27)  0.12 0.56 - 2.75 0.59     
Blood              
  Albumin               
      Average (>35g/L)  124   41.9 (52)  Reference group      
      Below Average (≤35g/L)  22   86.4 (19)  8.81 1.82 – 42.6 0.007  0.86 0.12- 6.5 0.88 
  Hemoglobin               
     Average (>120g/L)  117   42.7 (50)  Reference group      
     Below Average (≤120g/L)  36   69.4 (25)  3.21 1.31-7.68 0.01  2.11  0.65-6.86 0.21 
  Lymphocytes               
     Average (1.5-4.0x109/L)  109   44.0 (48)  Reference group      
    Below Average (≤1.5x109/L)  44   64.4 (27)  1.46 0.66 -3.22 0.35     
FACT-G global score  157   [75.3 ± 16.9]4  0.95 0.93 – 0.98 <0.001  0.96 0.93- 0.99 0.007 
Nutritional assessment              
    PG-SGA score  157   [9.5 ± 6.6]4  1.13 1.05 - 1.22 0.001  0.94 0.84- 1.06 0.33 
    PG-SGA A  118   39.3  (44)  Reference group      
    PG-SGA B and C  39   82.1 (32)  6.89 2.48 – 19.2 <0.001  5.28 0.98- 28.5 0.05 
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Table 1 continued    
     % (n)  with  Univariate model 1  Multivariable  model 3  
  N   prolonged LOS  OR 95% CI P  OR 95% CI P 
Histology and Stage              
   Benign/LMP/ OvCa stage I or II4  81   42.0 (34)  Reference group   
   OvCa stage III or IV  23   95.7 (22)  30.4 3.9-236.7 0.001  14.7 1.61-134.7 0.02 
   Endometrial cancer  36   50.0 (18)  1.38 0.63-3.04 0.42  1.71 0.67-4.34 0.002 
   Cervical cancer   22   11.8 (2)  0.18 0.04-0.86 0.03  0.10 0.01-0.71 0.02 
1adjusted for age and surgical approach; 2 Multivariable model including albumin, FACT-G score, PG-SGA score and PG-SGA global rating; adjusted for age and surgical 
approach; 3 Continuous variables: mean ± standard deviation for group with average LOS; 4Continuous variables: mean ± standard deviation for group with prolonged LOS ;  
Abbreviations: LOS, Length of hospital stay; OR, Odds Ratio; CI, Confidence interval; PG-SGA, Patient-Generated Subjective Global Assessment; FACT-G, Functional 
Assessment of Cancer Therapy-General. 
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